Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
McKinsey
US Army
UBS
Moodys
Johnson and Johnson
Fuji
Queensland Health

Generated: November 20, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: exenatide

« Back to Dashboard

exenatide

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Astrazeneca Ab BYDUREON BCISE exenatide SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS 209210 NDA AstraZeneca Pharmaceuticals LP 0310-6540-04 4 CARTRIDGE in 1 CARTON (0310-6540-04) > .85 mL in 1 CARTRIDGE (0310-6540-01)
Astrazeneca Ab BYDUREON BCISE exenatide SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS 209210 NDA AstraZeneca Pharmaceuticals LP 0310-6540-85 1 CARTRIDGE in 1 CARTON (0310-6540-85) > .85 mL in 1 CARTRIDGE
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Queensland Health
Cantor Fitzgerald
Deloitte
Accenture
Baxter
Merck
US Department of Justice
Fish and Richardson